Year : 2011 | Volume
: 15 | Issue : 3 | Page : 230-
|How to cite this article:|
. Erratum.Indian J Endocr Metab 2011;15:230-230
|How to cite this URL:|
. Erratum. Indian J Endocr Metab [serial online] 2011 [cited 2021 Apr 13 ];15:230-230
Available from: https://www.ijem.in/text.asp?2011/15/3/230/83416
Relationship of associated secondary hyperparathyroidism to serum fibroblast growth factor-23 in end-stage renal disease: A case control study
Hamdy Sliem, Gamal Tawfik, Fadia Moustafa 1 , Heba Zaki
Departments of Internal Medicine and 1 Clinical Pathology, Suez Canal University, Ismailia, Egypt
A misalignment occurred in [Table 2] of the article by Sliem et al., published in the April 2011, issue of IJEM. 1
The corrected table is printed below [Table 2].
Sliem H, Tawfik G, Moustafa F, Zaki H. Relationship of associated secondary hyperparathyroidism to serum fibroblast growth factor-23 in end stage renal disease: A case control study. Indian J Endocrinol Metab 2011;15:105-9.
The error is regretted.
Editor, Indian Journal of Endocrinology and Metabolism